ENTITY
WuXi AppTec

WuXi AppTec (603259 CH)

263
Analysis
Health CareChina
WuXi AppTec Co., Ltd. manufactures medical products. The Company produces biological agents, antibodies, biological diagnostic reagents, and other products. WuXi AppTec also provides biological analysis, technical study, and other services.
more
08 May 2019 15:36

Frontage Holdings IPO Preview: An Uncertain Transition

Frontage Laboratories Inc (1000371Z HK) is a global contract research organisation (CRO) which is backed by Hangzhou Tigermed Consulting (300347...

Logo
678 Views
Share
25 Apr 2019 15:29

Viva Biotech IPO: Just About Supporting the Low-End IPO Price Range

Viva Biotech Holdings (1873 HK) is a leading global contract research organisation (CRO). It has launched its IPO to raise net proceeds of HK$1,232...

Logo
683 Views
Share
23 Apr 2019 17:13

Viva Biotech (维亚生物) IPO: Valuation Rich Even at Low End

Viva Biotech launched book building today to raise up to USD 194 million via its Hong Kong IPO. In our previous insights, we have discussed the...

Logo
672 Views
Share
22 Apr 2019 15:33

Viva Biotech IPO Preview: Show Me the Money

Viva Biotech Shanghai Ltd (1577881D HK) is a leading global contract research organisation (CRO). Viva has started pre-marketing for a Hong Kong...

Logo
606 Views
Share
28 Mar 2019 15:48

Viva Biotech (维亚生物) IPO: Warning Signs from 2018 Numbers (Part 2)

Viva Biotechnology, a China-based drug discovery company, is seeking to raise USD 200m to list on the Hong Kong Stock Exchange. It has recently...

Logo
808 Views
Share
x